National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 366697

Government Disclaimer on use of this data

Case Details

VAERS ID: 366697 (history)  
Form: Version 1.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:0
Submitted: 2009-11-11
   Days after onset:61
Entered: 2009-11-10
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Mental disorder, Nausea, Schizophrenia, Suicidal ideation, Vomiting
SMQs:, Acute pancreatitis (broad), Suicide/self-injury (narrow), Dementia (broad), Psychosis and psychotic disorders (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC Split Type: B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166